| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K Prank, M Kloppstech, G Braban. Neural networks in the analysis of episodic growth hormone release. Human reproduction update. vol 3. issue 3. 1997-10-30. PMID:9322099. |
comparing the predictive results for the gh dynamics with those for computer-stimulated stochastic processes, we were able to define the irregular pattern of gh secretion in acromegaly as a random autonomous process. |
1997-10-30 |
2023-08-12 |
human |
| G Mohr, Z P Chen, M Schweitze. Acromegaly with normal basal growth hormone levels. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 24. issue 3. 1997-10-16. PMID:9276113. |
the most common cause of acromegaly is excess of growth hormone (gh) secretion. |
1997-10-16 |
2023-08-12 |
Not clear |
| J B Corcuff, C Ogor, V Kerlan, M B Rougier, M Bercovichi, P Roge. Ocular naevus and melanoma in acromegaly. Clinical endocrinology. vol 47. issue 1. 1997-10-16. PMID:9302382. |
acromegaly favours the development of extrapituitary neoplasms presumably promoted through increased gh and igf-i levels. |
1997-10-16 |
2023-08-12 |
human |
| K Asai, S Shimoyama, N Sanno, M Kaminishi, T Oohar. A rare case of gastric cancer in an acromegalic patient. Journal of gastroenterology. vol 32. issue 4. 1997-10-09. PMID:9250902. |
this patient showed typical clinical features of acromegaly, with increased concentrations of blood growth hormone (gh) and insulin-like growth factor i (igf-i); she had four types of neoplasms; gastric cancer, colon tubular adenoma with moderate atypia, pancreatic mucinous cystadenoma, and subcutaneous lipoma. |
1997-10-09 |
2023-08-12 |
Not clear |
| G Sassolas, R Cohen, J J Tsat. [Strategy of exploration of states of growth hormone hypersecretion]. Nuclear medicine and biology. vol 21. issue 3. 1997-09-18. PMID:9296764. |
in contrast, igf-1 concentrations are high and correlated with gh levels during permanent gh hypersecretion that occurs in acromegaly. |
1997-09-18 |
2023-08-12 |
Not clear |
| S N Jackson, J Fowler, T A Howlet. Cabergoline treatment of acromegaly: a preliminary dose finding study. Clinical endocrinology. vol 46. issue 6. 1997-09-15. PMID:9274706. |
we therefore sought to investigate the effect of cabergoline on growth hormone (gh) secretion in acromegaly and to define the most appropriate dose for suppression of gh design and measurements: patients with active acromegaly (defined as most recent random gh > 5 mu/l) were identified from the departmental clinical information system. |
1997-09-15 |
2023-08-12 |
Not clear |
| S N Jackson, J Fowler, T A Howlet. Cabergoline treatment of acromegaly: a preliminary dose finding study. Clinical endocrinology. vol 46. issue 6. 1997-09-15. PMID:9274706. |
after informed consent was obtained, basal gh levels were estimated during a 5 point day curve at least 2 months after withdrawal of any existing medical therapy for acromegaly. |
1997-09-15 |
2023-08-12 |
Not clear |
| B L Silverman, J R Friedlande. Is growth hormone good for the heart? The Journal of pediatrics. vol 131. issue 1 Pt 2. 1997-09-04. PMID:9255233. |
gh excess (acromegaly) results in cardiac hypertrophy that can progress to cardiac failure. |
1997-09-04 |
2023-08-12 |
Not clear |
| I Yang, S Park, J Woo, S Kim, J Kim, Y Kim, Y Cho. Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients. The Journal of clinical endocrinology and metabolism. vol 82. issue 8. 1997-08-28. PMID:9253323. |
this study supports the idea that a reduction of hsa is not a primary cause of acromegaly, and the hsa seems to increase to suppress the autonomous secretion of gh from the pituitary adenomas. |
1997-08-28 |
2023-08-12 |
Not clear |
| Y Okada, I Morimoto, K Ejima, K Yoshida, M Kashimura, T Fujihira, S Et. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocrine journal. vol 44. issue 1. 1997-08-20. PMID:9152623. |
her serum gh and igf-1 levels in late pregnancy were different from the levels in pregnant women with acromegaly reported previously. |
1997-08-20 |
2023-08-12 |
Not clear |
| K C Tan, S W Shiu, E D Janus, K S La. LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I. Atherosclerosis. vol 129. issue 1. 1997-06-19. PMID:9069518. |
in contrast, gh and hdl were the main determinants in acromegaly, accounting for 32 and 24% in the variability of ldl-iii respectively. |
1997-06-19 |
2023-08-12 |
human |
| M Wada, H Azuma, H Bando, Y Shintani, S Saito, M Tamaki, H Ari. A case report of an elderly patient with acromegaly. Endocrine journal. vol 43. issue 6. 1997-05-29. PMID:9075612. |
the patient was diagnosed as having acromegaly due to overproduction of gh from a pituitary tumor. |
1997-05-29 |
2023-08-12 |
Not clear |
| N A Wong, J A Ahlquist, C Camacho-Hübner, C J Goodwin, M Dattani, N J Marshall, J A Was. Acromegaly or chronic renal failure: a diagnostic dilemma. Clinical endocrinology. vol 46. issue 2. 1997-05-28. PMID:9135706. |
uraemic patients may have markedly elevated serum gh concentrations yet, for hitherto unknown reasons, they do not develop acromegaly. |
1997-05-28 |
2023-08-12 |
Not clear |
| N A Wong, J A Ahlquist, C Camacho-Hübner, C J Goodwin, M Dattani, N J Marshall, J A Was. Acromegaly or chronic renal failure: a diagnostic dilemma. Clinical endocrinology. vol 46. issue 2. 1997-05-28. PMID:9135706. |
review of the patient's relatives and the findings of a normal serum igf-i concentration and a normal pituitary fossa on magnetic resonance imaging, suggest that the patient's acromegalic appearance is a familial trait and his abnormal gh dynamics a result of his renal failure rather than acromegaly. |
1997-05-28 |
2023-08-12 |
Not clear |
| N A Wong, J A Ahlquist, C Camacho-Hübner, C J Goodwin, M Dattani, N J Marshall, J A Was. Acromegaly or chronic renal failure: a diagnostic dilemma. Clinical endocrinology. vol 46. issue 2. 1997-05-28. PMID:9135706. |
these changes, together with reduced igf-i bioactivity, may explain why patients with chronic renal failure do not develop acromegaly in the presence of abnormally elevated levels of gh. |
1997-05-28 |
2023-08-12 |
Not clear |
| C L Boguszewski, G Johannsson, B A Bengtsson, A Johansson, B Carlsson, L M Carlsso. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery. The Journal of clinical endocrinology and metabolism. vol 82. issue 5. 1997-05-23. PMID:9141543. |
there have been reports suggesting that circulating non-22k gh isoforms are increased in acromegaly, but the possible implications of such observations in the management of the disease have not been addressed. |
1997-05-23 |
2023-08-12 |
Not clear |
| C L Boguszewski, G Johannsson, B A Bengtsson, A Johansson, B Carlsson, L M Carlsso. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery. The Journal of clinical endocrinology and metabolism. vol 82. issue 5. 1997-05-23. PMID:9141543. |
the aim of this study was to evaluate the proportion of circulating non-22k gh isoforms in acromegaly. |
1997-05-23 |
2023-08-12 |
Not clear |
| K K Ho, A J O'Sullivan, D M Hoffma. Metabolic actions of growth hormone in man. Endocrine journal. vol 43 Suppl. 1997-05-22. PMID:9076343. |
the significance of these effects is reflected in the finding of increased adiposity in gh deficiency (ghd) and reduced fat mass in acromegaly. |
1997-05-22 |
2023-08-12 |
Not clear |
| K K Ho, A J O'Sullivan, D M Hoffma. Metabolic actions of growth hormone in man. Endocrine journal. vol 43 Suppl. 1997-05-22. PMID:9076343. |
extracellular water volume is diminished in ghd and increased in relation to the extent of gh excess in acromegaly. |
1997-05-22 |
2023-08-12 |
Not clear |
| R López-Velasco, H F Escobar-Morreale, B Vega, E Villa, J M Sancho, J L Moya-Mur, R García-Roble. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? The Journal of clinical endocrinology and metabolism. vol 82. issue 4. 1997-05-06. PMID:9100571. |
to evaluate the relative contributions of past or present gh hypersecretion and of hypertension to the cardiac abnormalities present in acromegaly, we have studied the serum gh and insulin-like growth factor i concentrations, systolic and diastolic blood pressures, and morphological and functional cardiac indexes as measured by echocardiography-doppler, in 39 patients with active or cured acromegaly, 16 hypertensive controls, and 17 normotensive controls. |
1997-05-06 |
2023-08-12 |
Not clear |